• Contemporary ClinicContemporary Clinic
  • OTC GuideOTC Guide
  • Pharmacy Times
  • PTCEPTCE
  • Pharmacist Moms GroupPharmacist Moms Group
News
All News
FDA Updates
Press Releases
Media
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conferences
Conference Coverage
Conference Listing
Publications
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
Clinical
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Events
Upcoming Events
Upcoming Webinars
CE
Resources
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
logo
Spotlight
Community/RetailHospitalOncologyPharmacy TechnicianStudent
Clinical Role
Community/RetailHospitalOncologyPharmacy TechnicianSpecialty PharmacyStudent
Clinical
CoronavirusBrain HealthCardiovascular HealthDermatologyDiabetesFluHeart FailureHepatitis/MASHImmunizationMigrainePneumococcalVitamins and Supplements
Supplement Spotlight
October 2023 Pharmacy Technician Edition
All News
FDA Updates
Press Releases
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conference Coverage
Conference Listing
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Upcoming Events
Upcoming Webinars
CE
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
Advertisement

CLINICAL ROLE -

Community/Retail
| Hospital
| Oncology
| Pharmacy Technician
| Student

Article

November 21, 2016

Link Between Rheumatoid Arthritis and Heart Disease Raises Questions

Author(s):

Ryan Black

Growing evidence points to the relationship between rheumatoid arthritis and heart problems.

With ever-growing data that the inflammation in rheumatic conditions can go hand-in-hand with cardiovascular inflammation, two different studies presented in press conferences at the 2016 American College of Rheumatology Annual Meeting in Washington, DC sought to broaden rheumatology’s approach to dangerous conditions it may influence.

Speaking on behalf of his team at the VU University Medical Center in Amsterdam, Mike T. Nurmohamed, MD, presented findings from the CARRE study that began in 2001, when data on the relationship between rheumatoid arthritis (RA) and heart problems was far more sparse than it is today.

Their cohort included a random sample of 353 long-term RA patients assessed at 3, 10, and 15-year follow-ups.

During the 2703 person-years of follow-up, they found a rate of 3.6 cardiovascular disease (CVD) events per 100 person-years. The general population assessment put the incidence rate at 1.4 per 100 person-years. In that general population, they found that a number of them had type-2 diabetes, and that risk among RA patients and diabetes patients was similar. Even excluding patients with pre-existing known risk factors for CVD, they found that RA patients were still 70% more at risk than the general population group.

In clinical practice Nurmohamed said this indicated a need for better screening and treatment of RA patients for cardiovascular risk factors, and that there was increasing evidence that certain biologic therapy did decrease cardiovascular risk.

His speech was followed by one from Iris Navarro-Milan of the University of Alabama at Birmingham, who detailed the necessity of exploring hyperlipidemia alongside rheumatoid arthritis. Hyperlipidemia, a concentration of lipids in the blood, is a major risk factor for CVD.

She began her speech by claiming that “One of the most successful stories in rheumatology is the achievement of remission in patients with rheumatoid arthritis. However, this is tempered by the fact that our patients still continue to face a high risk of mortality from cardiovascular disease.”

Previous data suggests that RA patients are under-screened for hyperlipidemia, and they wanted to see if rheumatologists could have an impact in changing that. Over a million Americans have RA, and Navarro-Milan’s study used claims data from both Medicare/Medicaid and private insurance to evaluate the nature of lipid screenings among such patients.

Excluding patients who had previously experienced myocardial infarction (MI), stroke, or coronary heart disease (CHD), as well as those already diagnosed with hyperlipidemia, they identified over 13,000 patients with rheumatoid arthritis. A large majority, 83%, were female.

They found that 18% of the total group did not receive care from a primary care physician (PCP), and among patients older than 65, the number was closer to 30%. In patients who were only treated by a rheumatologist, only 40% were screened for hyperlipidemia, similar to the 42% who exclusively saw a PCP and were screened. Even among those who saw both, only 47% were screened, but they did find that combined care increased likelihood of screening by 32%

She says her group’s work highlights the need for coordination of care, and that despite successes, the rate of remission in RA patients remains low-even by the loosest definitions, still less than a quarter of patients. The question, she asks, is “What are we going to do for the other 75% that do not achieve remission to treat their cardiovascular risk? It’s to still pay attention to their other cardiovascular risk factors, such as hyperlipidemia. We could coordinate care between specialties, but sometimes the issue is: who takes ownership of the problem?”

Related Videos
Menoapuse spelled with wooden blocks -- Image credit: loran4a | stock.adobe.com
Related Content
Advertisement
psoriasis is an autoimmune human disease. a man holds a hand at a psoriasis affected area of the skin
May 14th 2025

Icotrokinra Demonstrates Significant Skin Clearance in Difficult-to-Treat Scalp, Genital Psoriasis

Luke Halpern, Assistant Editor
Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education
February 28th 2025

Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education

Luke Halpern, Assistant Editor Jill Simonian, PharmD Codi Peterson, PharmD, MS
Doctor hold Blood sample for Primary Immunodeficiency (PID) test. Medical testing concept with laboratory background.
May 13th 2025

Mild to Moderate Adverse Events Possible in Pediatric Patients With Primary Immunodeficiency Receiving IVIG

Luke Halpern, Assistant Editor
Pharmacy Focus: World Psychedelics Day
June 14th 2024

Pharmacy Focus: World Psychedelics Day

Ashley Gallagher, Editor
Ozempic, Mounjaro and Wegovy injectable pens on white background - Image credit: K KStock | stock.adobe.com
May 12th 2025

Expert Q&A: Expanding the Pharmacist's Role in Community-Based Weight Management

Emilie Collongette, PharmD, CPh, BCMTMS Kennedy Ferruggia, Assistant Editor
Pharmacist Champion Role Improves Access to Resmetirom for MASH
May 12th 2025

Pharmacist Champion Role Improves Access to Resmetirom for MASH

Brian Gaul, PharmD
Related Content
Advertisement
psoriasis is an autoimmune human disease. a man holds a hand at a psoriasis affected area of the skin
May 14th 2025

Icotrokinra Demonstrates Significant Skin Clearance in Difficult-to-Treat Scalp, Genital Psoriasis

Luke Halpern, Assistant Editor
Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education
February 28th 2025

Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education

Luke Halpern, Assistant Editor Jill Simonian, PharmD Codi Peterson, PharmD, MS
Doctor hold Blood sample for Primary Immunodeficiency (PID) test. Medical testing concept with laboratory background.
May 13th 2025

Mild to Moderate Adverse Events Possible in Pediatric Patients With Primary Immunodeficiency Receiving IVIG

Luke Halpern, Assistant Editor
Pharmacy Focus: World Psychedelics Day
June 14th 2024

Pharmacy Focus: World Psychedelics Day

Ashley Gallagher, Editor
Ozempic, Mounjaro and Wegovy injectable pens on white background - Image credit: K KStock | stock.adobe.com
May 12th 2025

Expert Q&A: Expanding the Pharmacist's Role in Community-Based Weight Management

Emilie Collongette, PharmD, CPh, BCMTMS Kennedy Ferruggia, Assistant Editor
Pharmacist Champion Role Improves Access to Resmetirom for MASH
May 12th 2025

Pharmacist Champion Role Improves Access to Resmetirom for MASH

Brian Gaul, PharmD
Consent Preferences
About Us
Clinical Forums
Advertise
Contact Us
Editorial Staff
Privacy Policy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.